Menopause: The Physiological Cliff May Begin Decades Before We See It

Beyond hormonal decline: How cumulative stress, bioenergetic constraints, and declining recovery capacity may shape the transition into menopause and later-life health.

Menopause is commonly described as the end of a woman's reproductive years, when ovarian follicles become depleted, estrogen production declines, and menstruation eventually stops.

But this explanation leaves a more fundamental question unanswered:

Why does the body's capacity to maintain ovarian function progressively decline in the first place?

And why do some women pass through menopause with relatively few difficulties, while others experience profound changes in sleep, cognition, metabolism, cardiovascular function, bone health, and quality of life?

Two important articles published in October 2026 offer new perspectives.

A review in Science, “Reframing menopause and menopause hormone therapy as opportunities for healthy aging,” argues that menopause is a whole-body biological transition rather than an isolated reproductive event.

Meanwhile, a large population-scale study in Nature Medicine, “Population-scale reconstruction of menopause dynamics reveals a physiological cliff at the final menstrual period,” demonstrates that menopause is associated with surprisingly abrupt changes across numerous physiological systems.

Together, these papers invite a different way of thinking about menopause.

What if the physiological cliff observed at menopause is not the beginning of systemic dysfunction, but the visible manifestation of a much longer process of declining physiological reserve?

This possibility becomes especially interesting when considered through the interconnected concepts of the exposome, stress adaptation, bioenergetic impedance, allostatic triage, and recovery dynamics.

Menopause is not simply an estrogen deficiency

The Science review, led by Laura Gravelsins and colleagues, highlights how profoundly menopause affects the entire body.

Estrogen and progesterone receptors are distributed across multiple tissues, including the brain, heart, liver, kidneys, bones, muscles, adipose tissue, and immune system.

Consequently, menopause is associated with far more than hot flashes or irregular menstrual cycles.

Women may experience changes involving cognition, mood, sleep, body composition, metabolic regulation, vascular function, bone remodeling, immune signaling, and gastrointestinal or urogenital function.

The review describes at least 72 reported symptoms associated with menopause, although their severity and duration vary substantially between individuals.

Importantly, these changes cannot be explained by chronological aging alone.

The timing of menopause, whether it occurs spontaneously or follows ovarian surgery, previous hormonal exposures, reproductive history, and individual sensitivity to hormonal fluctuations can all influence subsequent health trajectories.

The authors therefore propose that menopause should be regarded as an important opportunity for personalized healthy-aging care.

Yet their discussion also raises a deeper biological issue.

If menopause is associated with changes throughout the body, should we understand it solely as the consequence of reduced ovarian hormone production?

Or might ovarian decline and broader systemic aging processes be interconnected?

The discovery of a physiological cliff

The Nature Medicine study, led by Glen Pridham and colleagues, provides an especially compelling temporal perspective.

The researchers analyzed more than 300 million laboratory tests from two large healthcare datasets in the United States and Israel, encompassing more than one million women.

Ordinarily, age-related laboratory trends appear gradual because women experience menopause at different ages.

The investigators developed a computational method to reconstruct these trends relative to the final menstrual period, rather than chronological age alone.

Once the data were aligned in this way, a striking pattern emerged.

Menopause was associated with relatively abrupt, step-like physiological changes across numerous organ systems.

Of 90 laboratory measures examined, 52 demonstrated statistically significant female-specific changes around menopause, compared with male aging trajectories.

These changes extended beyond reproductive hormones to include bone metabolism, liver function, cholesterol and lipid regulation, blood chemistry, iron metabolism, and fluid balance.

The patterns were broadly consistent between the American and Israeli populations.

The researchers called this phenomenon a physiological cliff.

Notably, the majority of these changes moved in directions associated with increased health risks, although iron-related markers often improved following the cessation of menstrual bleeding.

This was not simply a pattern of ordinary chronological aging. Comparable abrupt changes were not observed in men.

Nevertheless, the cliff represents a reconstructed population-average transition, not proof that every woman experiences a sudden biological event at precisely the final menstrual period.

The finding is important because it suggests that menopause is associated with a coordinated reorganization of multiple physiological systems.

But the most interesting discovery may have occurred much earlier.

The transition begins more than a decade before menopause

The researchers reconstructed the trajectories of several reproductive hormones preceding the final menstrual period.

They identified three important patterns:

• Anti-Müllerian hormone (AMH), a marker associated with ovarian follicular reserve, began an accelerated decline approximately 15 years before menopause.

• Follicle-stimulating hormone (FSH) began an accelerated rise approximately 14 years before menopause.

• Estradiol began an accelerated decline approximately 12 years before menopause.

These are population-level estimates rather than precise biological milestones applicable to every woman.

Nevertheless, they demonstrate that measurable endocrine reorganization begins long before menstruation finally stops.

This sequence is especially informative.

AMH decline suggests progressive changes in ovarian follicular reserve.

Rising FSH reflects increasing compensatory signaling from the hypothalamic–pituitary system as ovarian feedback becomes less effective.

Eventually, estradiol production becomes increasingly difficult to sustain.

The body is not simply shutting down reproductive function overnight.

It has been undergoing years of progressive change and endocrine compensation.

The final menstrual period is therefore a recognizable landmark in a transition that began much earlier.

But what determines the rate of this long-term deterioration?

Looking upstream: Why does ovarian reserve deteriorate?

The conventional explanation of menopause emphasizes progressive depletion of ovarian follicles.

Human females begin life with a largely finite ovarian follicular reserve. Over subsequent decades, follicles are recruited, mature, or undergo atresia, and the reserve progressively declines.

This is an established feature of human reproductive biology.

However, describing follicular depletion does not fully explain why the rate of depletion differs among women.

Long-lived ovarian follicles must preserve cellular integrity over decades.

Their survival depends on processes involving DNA damage responses, mitochondrial quality control, cellular redox regulation, protein maintenance, autophagy, and interactions with surrounding ovarian tissues.

These processes require coordinated metabolic support.

They also depend on an appropriate balance between follicular dormancy and activation.

Excessive growth signaling can prematurely exhaust the reserve, whereas appropriately regulated dormancy helps preserve it.

In other words, ovarian longevity depends not simply on hormone production but on the body's ability to maintain and protect a finite biological reserve.

This raises an important possibility.

Could the progressive deterioration of ovarian reserve partly reflect a long-term imbalance between accumulated biological stress and the capacity for cellular maintenance and repair?

To explore that question, we need to look beyond reproductive endocrinology.

The exposome: The accumulated burden of living

Throughout life, the body must continually respond to environmental and internal demands.

These include nutritional insufficiencies, toxicant exposures, infections, inflammatory challenges, disrupted sleep, psychological stress, metabolic disturbances, and physical workloads.

Collectively, these exposures and their biological consequences can be understood through the concept of the exposome.

Importantly, the body does not respond passively.

It continually adjusts metabolism, immune activity, endocrine signaling, cardiovascular function, and cellular repair processes to preserve essential physiological functions.

These responses are frequently beneficial.

Inflammation helps defend against infection. Stress hormones support immediate demands. Metabolic flexibility enables the mobilization and redistribution of energy.

However, the biological consequences may differ when challenges are prolonged, repeated, or insufficiently resolved.

Every response has requirements for energy, nutrients, signaling coordination, and eventual recovery.

Over time, persistent physiological demands may contribute to an increasing burden on the mechanisms needed to maintain long-term tissue integrity.

This is where our proposed bioenergetic impedance framework becomes relevant.

Bioenergetic impedance: When adaptive demand

exceeds functional capacity

Bioenergetic impedance describes a time-dependent constraint on the ability of biological systems to sustain energetic throughput and recover relative to physiological demand.

It is not simply a shortage of calories or ATP.

Functional constraints can arise from impaired substrate handling, mitochondrial dysfunction, altered oxygen delivery, inflammatory signaling, inefficient metabolic pathways, or disrupted tissue coordination.

A system may continue functioning despite these constraints by recruiting compensatory mechanisms.

But preserving immediate function does not necessarily mean that the underlying disturbance has resolved.

Compensation may require additional resources, alter metabolic organization, or reduce capacity to respond to subsequent challenges.

Under persistent constraints, biological systems may face increasingly difficult trade-offs between immediate function and long-term maintenance.

This brings us to the concept of allostatic triage.

Allostatic triage: What does the body maintain when resources become constrained?

The body must continuously balance competing physiological priorities.

In our proposed framework, these priorities can be described across four broad functional domains:

Vital functions: Immediate physiological stability and survival.

Stress adaptation: Responses required to handle current environmental or internal demands.

Growth, Maintenance and Repair (GMR): Cellular renewal, damage repair, tissue integrity, and functional restoration.

Long-term reserve: The capacity to preserve health, resilience, and future physiological options across years and decades.

These are interconnected functions rather than rigid biological compartments.

Under favorable conditions, sufficient resources may be available to support all four.

During prolonged stress, however, immediate physiological demands may receive greater functional priority, potentially constraining processes required for long-term tissue maintenance.

This does not imply a simple diversion of calories or cholesterol away from reproduction. The mechanisms may involve changes in cellular signaling, mitochondrial function, immune regulation, endocrine feedback, and tissue-specific maintenance pathways.

Nor does it mean that reduced growth is always harmful. In ovarian biology, regulated suppression of follicular activation can be protective.

The central hypothesis is more specific:

When accumulated biological demands chronically exceed recovery capacity, the balance between tissue damage, maintenance, repair, and long-term reserve preservation may progressively deteriorate.

Over decades, such constraints could plausibly contribute to accelerated ovarian aging.

The ovarian follicular reserve is particularly vulnerable to cumulative loss because depleted follicles cannot ordinarily be replaced.

This provides a possible mechanistic bridge between long-term systemic stress adaptation and the progressive deterioration of reproductive function.

It remains a hypothesis, not a demonstrated universal cause of menopause.

From ovarian reserve erosion to systemic transition

We can now revisit the timeline revealed by the Nature Medicine study.

Imagine an individual accumulating physiological burdens over many years.

Initially, compensatory mechanisms may preserve apparently normal function.

Hormonal levels remain within expected ranges. Menstrual cycles continue. Daily activities remain manageable.

Yet maintaining this apparent stability could become progressively more demanding if underlying cellular maintenance and recovery capacity are deteriorating.

Over time, ovarian reserve declines.

AMH levels begin falling more rapidly.

The hypothalamic–pituitary system responds by increasing gonadotropin signaling, particularly FSH, in an attempt to sustain follicular activity and ovarian hormone production.

Eventually, ovarian responsiveness becomes insufficient to maintain the previous endocrine configuration.

Estradiol production changes, menstrual cycles become increasingly irregular, and the reproductive system transitions toward menopause.

Because ovarian hormones participate in regulation across multiple organs, these endocrine changes are accompanied by reorganization in skeletal, hepatic, metabolic, vascular, neural, and other systems.

The resulting changes become visible as the physiological cliff described by Pridham and colleagues.

From the proposed bioenergetic perspective, this sequence may be understood as:

Cumulative exposures → persistent adaptive demands → bioenergetic constraints → altered allostatic priorities → impaired maintenance and repair → progressive reserve erosion → endocrine compensation → systemic physiological transition.

This is not a causal sequence demonstrated by either article. It is a mechanistic model proposed to connect their observations with broader processes of biological aging.

Importantly, genetics, developmental ovarian reserve, normal follicular recruitment, and intrinsic oocyte aging remain major determinants of menopause. Exposome-related GMR impairment may modify the timing and consequences of this process without replacing those established mechanisms.

Menopause as a systemic state transition

This perspective has an interesting parallel with cellular senescence.

Cellular senescence involves a relatively stable reorganization of cellular function in response to biological stresses, often accompanied by changes in metabolism, signaling, and inflammatory activity.

Menopause is not cellular senescence occurring across the entire body. It is a distinct physiological endocrine transition.

Nevertheless, both processes illustrate how biological systems can shift from one operating configuration to another.

The system does not simply lose a function. It reorganizes around altered constraints and signaling conditions.

The Science review emphasizes that the postmenopausal ovary itself remains biologically active, with ongoing androgen production, immune signaling, and tissue remodeling.

Similarly, the Nature Medicine study demonstrates that menopause is associated with coordinated changes in multiple physiological systems.

Together, these observations make it reasonable to investigate menopause as a systemic state transition with a prolonged preceding phase of declining reserve and compensation.

The crucial question then becomes not only when the transition occurs, but how successfully the body adapts to its new operating state.

Recovery dynamics: Why do women follow different aging trajectories?

Not every woman experiences the same menopause.

Some report relatively few symptoms and maintain good physical and cognitive function.

Others experience substantial sleep disturbance, metabolic dysregulation, changes in body composition, depression, cognitive complaints, or prolonged vasomotor symptoms.

The Science review emphasizes that these outcomes depend on menopause timing, hormonal sensitivity, reproductive history, genetics, and previous hormone exposures.

But recovery capacity may provide an additional explanatory dimension.

Following a significant physiological transition, the body must reorganize its regulatory networks.

Some adaptations may stabilize efficiently.

Others may require persistent compensation.

And in some individuals, previous disturbances may leave lasting biological effects, even after the initiating conditions have changed.

This persistence is related to the concept of hysteresis, in which a system's present state depends partly on its previous history.

For menopause, the hypothesis would be that women entering the transition with different accumulated exposures, tissue reserves, and recovery capacities may follow different postmenopausal trajectories, even when circulating hormone levels are similar.

A relatively resilient system might establish a sustainable postmenopausal configuration.

A system already experiencing substantial bioenergetic constraints may struggle to accommodate additional changes in endocrine, skeletal, metabolic, and immune regulation.

Consequently, symptoms and compensatory disturbances may persist.

These possibilities require longitudinal validation. Persistent symptoms alone do not establish hysteresis or bioenergetic failure.

Nevertheless, recovery dynamics provide a potentially useful framework for investigating why the same hormonal transition can lead to different health outcomes.

What does hormone therapy tell us?

Both papers discuss menopausal hormone therapy, but from different perspectives.

The Science review emphasizes that hormone therapies are highly heterogeneous.

Their effects depend on estrogen type, progestogen formulation, route of administration, dose, timing, duration, and individual history.

The Nature Medicine study reports that women using hormone therapy generally exhibited smaller menopause-associated changes in several laboratory domains, particularly skeletal, hepatic, and renal measures.

This suggests that altered ovarian hormone signaling is an important contributor to the physiological cliff.

However, hormone therapy does not necessarily restore the ovarian follicular reserve or reverse the biological processes responsible for ovarian aging.

From our proposed framework, hormone therapy may help modify the downstream systemic consequences of the endocrine transition without necessarily correcting all upstream constraints on maintenance, repair, or recovery.

That distinction is important.

It does not reduce the established clinical value of appropriately selected hormone therapy for menopausal symptoms and certain bone-health indications.

Rather, it raises the possibility that optimal menopause care may need to address both endocrine changes and the broader physiological condition of the individual.

The clinical opportunity may begin long before menopause

If endocrine reorganization can begin more than a decade before the final menstrual period, there may be opportunities to investigate and support health much earlier.

The aim should not be to treat every woman in her thirties or forties as if she were approaching a disease state.

Menopause is a normal life transition, not a disorder that must be prevented.

Instead, attention could focus on preserving physiological capacity across the lifespan.

Potentially relevant areas include metabolic health, nutritional sufficiency, sleep quality, physical activity, muscle and bone reserve, environmental exposures, inflammatory burden, and the balance between physiological challenges and recovery.

These are established components of general health, although whether modifying them can substantially delay natural menopause remains uncertain.

For research, the more ambitious opportunity is to move beyond isolated hormone concentrations.

We could investigate the rate of ovarian reserve decline, the metabolic and inflammatory context in which it occurs, and how effectively individuals recover from standardized physiological challenges.

Such measurements might help distinguish normal reproductive aging from accelerated reserve erosion associated with broader systemic dysfunction.

The goal would be to identify not simply how much function remains, but how effectively the system maintains and restores that function over time.

A new question for healthy aging

The most important insight from these two papers may be that menopause is both a consequence of earlier biological changes and a contributor to later systemic reorganization.

The Nature Medicine study provides an increasingly detailed timeline of the transition.

The Science review explains why its manifestations and consequences differ across individuals.

Our proposed exposome–bioenergetic impedance–allostatic triage–recovery framework offers a potential upstream explanation connecting cumulative physiological demands with maintenance capacity, reserve erosion, compensatory adaptation, and eventual systemic reorganization.

This framework must still be tested. It does not establish that chronic stress causes natural menopause, that cortisol production diverts resources from ovarian hormones, or that all menopausal changes result from impaired bioenergetics.

But it generates a question worth investigating:

Could some of the variation in menopause timing and subsequent aging trajectories reflect how effectively the body has maintained, repaired, and recovered from cumulative physiological demands over preceding decades?

If so, the visible hormonal changes of menopause may tell only part of a much longer biological story.

The physiological cliff may be where the transition becomes most apparent—not where the process first began.

And perhaps the most important opportunity for healthy aging lies not merely in responding to the cliff, but in understanding and supporting the biological reserves that shape the journey toward it.

References

Gravelsins, L. L., Perović, M., Wood Alexander, M., Splinter, T. F. L., McGovern, A. J., Rabin, J. S., & Galea, L. A. M. (2026). Reframing menopause and menopause hormone therapy as opportunities for healthy aging. Science, 394(6819). https://doi.org/10.1126/science.aeg5004

Pridham, G., Hayut, Y., Lavi-Shoseyov, N., Neeman, M., Hovav, N., Toledano, Y., & Alon, U. (2026). Population-scale reconstruction of menopause dynamics reveals a physiological cliff at the final menstrual period. Nature Medicine. https://doi.org/10.1038/s41591-026-04614-0